Tracy Gayeski, Psy.D., MBA Chief Health Officer Dr. Tracy Gayeski serves as Catalight’s Chief Health Officer, bringing over 20 years of clinical and administrative leadership in developmental disabilities. Her unique qualifications — a licensed clinical neuropsychologist combined with an MBA in Healthcare Management — provide a comprehensive perspective on both clinical practice and system efficiency. As Chief Health Officer, Dr. Gayeski oversees all day-to-day operations, oversees the provider network activity and growth, and supports the Catalight Research Institute. This leadership ensures clinical practice is continually informed by cutting-edge findings and aligned with strategic operational goals. Dr. Gayeski commits to several key initiatives: expanding treatment modalities and choices, supporting high-performing teams, and utilizing a full suite of metrics to drive operational success and efficiency. She champions a dedicated person-centered approach, emphasizing the importance of actively integrating client and family perspectives with empirically based medical interventions. Before joining Catalight, Dr. Gayeski served in a significant director and practitioner role at Kaiser Permanente, where she oversaw complex programs including autism services, behavioral health clinics, and primary and specialty care psychology. She also worked as a neuropsychologist on a multidisciplinary rehabilitation team helping individuals with acquired brain injuries.
in the news | October 20, 2025 How Telemedicine Has Transformed One Autism and I/DD Provider Network Read News
in the news | November 25, 2024 Catalight Teams Up with AI Company Nabla to Reduce Clinician Workload Read News
article | August 27, 2024 Making a Global Impact: Achieve Australia Visits Catalight’s Walnut Creek Headquarters Read article
in the news | July 23, 2024 Autism Treatment Should be Guided by Recent Research Reflecting the Expansion of the Diagnoses Read News
article | May 31, 2024 Catalight’s New Post-Doctoral Training Program Aimed to Address Industry-Wide Shortage of Qualified Autism Evaluators and Long Diagnostic Wait Times Read article